Mantle cell lymphoma · 3 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Fludarabine and Rituximab (FR) Variant #06 | — | R 117 749 | 28d | — | — | — | — | — |
FCM Variant #01 | — | R 13 494 | 28d | — | — | — | — | — |
CHOP (Prednisolone) Variant #01 | — | R 878 | 21d | — | ~11.8 mo | — | — | 1 |
3 of 3 regimens shown